Replies to post #687375 on NorthWest Biotherapeutics Inc (NWBO)

[Pharmboy46]

I wanna say friends with benefits, but it also may be to make Advent jealous?

[eagle8]

Together they form a large platform!

GLTU

[The Danish Dude]

Three Revimmune entities.

SAS - France
Inc - US
Ltd - UK

Linda Powers director in US and UK and in full control. Revimmune trials with Interleukin-7 back more than a decade gets PR'ed as Revimmune Inc. Revimmune.com say Maryland Bethesda is head office. Head office address is same address as Northwest Bio Inc and Toucan Capital. Revimmune is assignee on combo patent from 2014. Interleukin-7 also called IL-7 is in many claims on the combo patent. Before 2012 it was called CYT-107 after the company Cytheris. Mac Cheever was working with it. He joined NWBO SAB in 2016. A couple of succesful trials with IL-7 and a dendritic cell vaccine. "Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine"

"The 5-year overall survival (OS) rates in paediatric patients with recurrent disease are 28% for rhabdomyosarcoma [7], 20% for neuroblastoma [4] and 23% for Ewing sarcoma [3], with little to no improvement in survival for recurrent and metastatic rhabdomyosarcoma and Ewing sarcoma for decades."
- courtesy dstock 🙏🏻

"Possible links of Linda Liau, DCVax and KLH (Keyhole Limpet Hemocyanin) (Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine used in trial) so certainly possible."
- courtesy Peter Brit



Revimmune Ltd dormant company but just been confirmed, that "its intended future activities are lawful" meaning ...



Industry Codes



There's more but I guess that ought to outline possibilities.

Oh, you will definitely see, that these informations shake the foundation of fudders narratives, so you should expect a major peak in the usual fud collateral damage 😊

Like ..... ohhhh its just about real estate 🥳